| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.2) | — | |
| Research & development | 5.9 | 5.5 | 6.6 | 5.0 | 3.2 | 1.8 | 2.0 | +5.4% | |
| Selling, general & administrative | 5.6 | 6.0 | 6.6 | 5.5 | 7.6 | 3.9 | — | — | |
| Selling & marketing | 0.6 | 1.1 | 1.4 | 0.8 | 0.6 | 0.2 | — | — | |
| Operating expenses | 11.5 | 11.5 | 13.2 | 10.5 | 10.8 | 5.8 | 6.6 | +14.7% | |
| Operating income | (11.5) | (11.5) | (13.2) | (10.5) | (10.8) | (5.8) | (6.6) | −15.4% | |
| Interest expense | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other income / expense | (0.2) | 0.3 | (0.0) | 0.5 | (0.7) | (1.3) | — | — | |
| Pre-tax income | (11.7) | (11.2) | (13.2) | (10.1) | (11.5) | (7.0) | (5.9) | +15.8% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (11.7) | (11.2) | (13.2) | (10.1) | (11.5) | (7.0) | (5.9) | +15.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (12.47) | (5.47) | (4.57) | (5.89) | (10.25) | (8.93) | (6.32) | +29.2% | |
| EPS, diluted (per share) | (12.47) | (5.47) | (6.84) | (5.89) | (10.25) | (8.93) | (6.38) | +28.6% | |
| EBITDA | (11.3) | (11.0) | (12.9) | (9.8) | (11.3) | (6.9) | (5.7) | +16.8% | |
| Depreciation & amortization | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | −56.3% | |
| Weighted average shares (shares) | 959,611 | 2,046,135 | 1,930,336 | 1,707,960 | 1,122,434 | 787,020 | — | — | |
| Weighted average diluted shares (shares) | 959,611 | 2,046,135 | 1,930,336 | 1,707,960 | 1,122,434 | 787,020 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
